Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries bioAffinity Technologies, Inc. - Common Stock (NQ: BIAF ) 2.420 -0.030 (-1.22%) Streaming Delayed Price Updated: 1:06 PM EDT, May 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 18,034 Open 2.490 Bid (Size) 2.380 (1) Ask (Size) 2.450 (1) Prev. Close 2.450 Today's Range 2.387 - 2.550 52wk Range 0.9548 - 3.620 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth April 24, 2024 From bioAffinity Technologies, Inc. Via Business Wire bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening April 09, 2024 From bioAffinity Technologies, Inc. Via Business Wire Performance YTD +43.20% +43.20% 1 Month +15.79% +15.79% 3 Month +51.25% +51.25% 6 Month +91.82% +91.82% 1 Year +18.05% +18.05% More News Read More 12 Health Care Stocks Moving In Friday's Intraday Session April 05, 2024 Via Benzinga BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q4 2023 April 01, 2024 Via InvestorPlace bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results April 01, 2024 From bioAffinity Technologies, Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's Intraday Session March 11, 2024 Via Benzinga Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 11, 2024 Via Benzinga Exposures Product Safety bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement March 08, 2024 From bioAffinity Technologies, Inc. Via Business Wire Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views March 06, 2024 Via Benzinga Topics Stocks Exposures US Equities Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 06, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session March 06, 2024 Via Benzinga Why BioAffinity Technologies (BIAF) Shares Are Down 50% March 06, 2024 Via Benzinga bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement March 06, 2024 From bioAffinity Technologies, Inc. Via Business Wire bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung March 05, 2024 From bioAffinity Technologies, Inc. Via Business Wire Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 05, 2024 Via Benzinga bioAffinity Technologies News Update February 21, 2024 From bioAffinity Technologies, Inc. Via Business Wire Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice February 06, 2024 From bioAffinity Technologies, Inc. Via Business Wire bioAffinity Technologies In The News January 30, 2024 From bioAffinity Technologies, Inc. Via Business Wire bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer January 23, 2024 From bioAffinity Technologies Via Business Wire bioAffinity Technologies In the News January 08, 2024 From bioAffinity Technologies Via Business Wire bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV January 05, 2024 Via ACCESSWIRE Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session December 19, 2023 Via Benzinga bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors December 05, 2023 From bioAffinity Technologies, Inc. Via Business Wire 12 Health Care Stocks Moving In Thursday's After-Market Session November 30, 2023 Via Benzinga CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024 November 30, 2023 From bioAffinity Technologies, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
